版權(quán)說明：本文檔由用戶提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、授予單位代碼 10089學(xué)號(hào)或申請(qǐng)?zhí)?20142439中國圖書分類號(hào) R735.2學(xué)術(shù)學(xué)位 學(xué)術(shù)學(xué)位膜聯(lián)蛋 膜聯(lián)蛋白A11對(duì)人胃癌細(xì)胞 對(duì)人胃癌細(xì)胞株SGC7901 5-Fu耐藥性影響 耐藥性影響及機(jī)制的研究 及機(jī)制的研究研 究 生： 趙一杰 趙一杰導(dǎo) 師： 李 勇 教 授檀碧波 檀碧波 副教授 副教授專 業(yè)： 外科學(xué) 外科學(xué)二 級(jí) 學(xué) 院 二 級(jí) 學(xué) 院 ： 河北醫(yī)科大學(xué)第四醫(yī)院 河北醫(yī)科大學(xué)第四醫(yī)院2017 年 3 月碩士學(xué)位論文H
2、ebei Medical University目 錄中文摘要·······························
3、3;····································&#
4、183;····································
5、···1英文摘要·································
6、;····································
7、83;····································&
8、#183;·5英文縮寫··································
9、····································
10、3;···································10研究論文 膜
11、聯(lián)蛋白 A11 對(duì)人胃癌細(xì)胞株 SGC7901 5-Fu 耐藥性影響及機(jī)制的研究前言·····························
12、3;····································&#
13、183;····································
14、···11材料與方法································
15、83;····································&
16、#183;························12結(jié)果···········&
17、#183;····································
18、;····································
19、83;·····················23附圖··············
20、83;····································&
21、#183;····································
22、;··················26附表··················
23、;····································
24、83;····································&
25、#183;··············39討論·····················&
26、#183;····································
27、;····································
28、83;···········41結(jié)論························
29、83;····································&
30、#183;····································
31、;········44參考文獻(xiàn)···························
32、83;····································&
33、#183;·································45綜述 氟尿嘧啶藥物的發(fā)展及胃癌
34、的耐藥機(jī)制····································
35、;········48致謝····························
36、;····································
37、83;····································&
38、#183;············59個(gè)人簡歷·······················
39、;····································
40、83;····································&
溫馨提示
- 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽，若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲(chǔ)空間，僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理，對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請(qǐng)與我們聯(lián)系，我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 膜聯(lián)蛋白A11對(duì)人胃癌細(xì)胞株AGS順鉑耐藥性影響及其機(jī)制的研究.pdf
- 三氧化二砷聯(lián)合5-Fu體外抗人胃癌細(xì)胞株SGC7901作用及機(jī)制的研究.pdf
- Celecoxib與5-Fu聯(lián)合應(yīng)用對(duì)人胃癌細(xì)胞系SGC7901增殖的影響.pdf
- 苦參堿逆轉(zhuǎn)人胃癌細(xì)胞株SGC7901-VCR耐藥性的實(shí)驗(yàn)研究.pdf
- siRNA干擾 E-cadherin表達(dá)對(duì)胃癌SGC7901細(xì)胞耐藥性影響及其機(jī)制研究.pdf
- 組織因子對(duì)人胃癌細(xì)胞株SGC7901體外侵襲能力的影響.pdf
- Wortmannin對(duì)人胃癌細(xì)胞SGC7901的影響及其機(jī)制研究.pdf
- 5-Fu溫?zé)峄煂?duì)人胃癌細(xì)胞株SGC-7901的促細(xì)胞凋亡作用及凋亡相關(guān)基因表達(dá)的影響.pdf
- 粉防已堿對(duì)胃癌耐藥細(xì)胞株SGC7901-VCR多藥耐藥性逆轉(zhuǎn)機(jī)制研究.pdf
- 姜黃素對(duì)SGC7901胃癌細(xì)胞株P(guān)300影響的相關(guān)研究.pdf
- 熱療對(duì)人胃癌耐藥細(xì)胞株SGC7901-DDP的影響及逆轉(zhuǎn)耐藥機(jī)制的研究.pdf
- 胃癌SGC7901-ADR細(xì)胞株β-catenin表達(dá)下調(diào)細(xì)胞株的建立及與多藥耐藥性的研究.pdf
- SGC-7901-5-FU人胃癌耐藥細(xì)胞株的建立及基因芯片檢測親本和耐藥細(xì)胞株的micro-RNA表達(dá)譜.pdf
- Survivin ASODN對(duì)胃癌細(xì)胞株SGC-7901增殖的影響.pdf
- siRNA介導(dǎo)NF-κB p65沉默聯(lián)合5-Fu誘導(dǎo)胃癌細(xì)胞SGC7901凋亡.pdf
- S100A6與胃癌細(xì)胞株SGC7901多藥耐藥的相關(guān)性研究.pdf
- 姜黃素體外逆轉(zhuǎn)人胃癌細(xì)胞SGC7901-VCR多藥耐藥性.pdf
- 淫羊藿苷(ICA)對(duì)胃癌細(xì)胞株SGC-7901增殖的影響.pdf
- 毛蘭素聯(lián)合5-Fu對(duì)人胃癌細(xì)胞株MGC-803增殖凋亡的影響.pdf
- TRAIL對(duì)胃癌細(xì)胞株SGC7901-VCR耐藥基因表達(dá)的影響及TRAIL聯(lián)合順鉑殺傷SGC7901-VCR的研究.pdf
評(píng)論
0/150
提交評(píng)論